BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2887113)

  • 1. Demonstration of specific E-type prostaglandin receptors using enriched preparations of canine parietal cells and [3H]misoprostol free acid.
    Tsai BS; Kessler LK; Schoenhard G; Collins PW; Bauer RF
    Am J Med; 1987 Jul; 83(1A):9-14. PubMed ID: 2887113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. E-type prostaglandin binding sites in isolated canine parietal cells: elucidation with (3H) misoprostol free acid.
    Tsai BS; Kessler LK; Schoenhard G; Collins PW; Bauer RF
    Z Gastroenterol; 1987 Apr; 25(4):201-6. PubMed ID: 2884786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of gastric antisecretory and prostaglandin E receptor binding activity of misoprostol by misoprostol free acid.
    Tsai BS; Kessler LK; Stolzenbach J; Schoenhard G; Bauer RF
    Dig Dis Sci; 1991 May; 36(5):588-93. PubMed ID: 1850690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preferential binding of the novel prostaglandin SC-46275 to canine gastric versus intestinal receptors.
    Tsai BS; Keith RH; Perkins WE; Walsh RE; Anglin CP; Collins PW; Gasiecki AW; Bauer RF; Jones PH; Gaginella TS
    J Pharmacol Exp Ther; 1995 Oct; 275(1):368-73. PubMed ID: 7562572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of prostaglandin E receptors in canine small intestine using [3H] prostaglandin E1 binding.
    Keith RH; Tsai BS; Collins PW; Perkins WE; Shone RL; Gasiecki AF; Bianchi RG; Bauer RF
    Prostaglandins; 1992 Dec; 44(6):579-95. PubMed ID: 1335587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antisecretory activity of misoprostol, its racemates, stereoisomers and metabolites in isolated parietal cells.
    Tsai BS; Kessler LK; Collins P; Kramer S; Bauer RF
    Prostaglandins; 1987; 33 Suppl():30-9. PubMed ID: 2827238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracellular coupling of prostaglandin inhibition of acid secretion in isolated rabbit gastric parietal cells.
    Choquet A; Leonard A; Magous R; Bali JP
    Biochem Pharmacol; 1990 Jun; 39(12):1905-11. PubMed ID: 1693850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pepsin release by prostaglandin E1 analogue. A potential therapeutic problem.
    Basson MD; Zucker KA; Adrian TE; Zdon MJ; Ballantyne GH; Modlin IM
    Arch Surg; 1988 Apr; 123(4):431-3. PubMed ID: 3126724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostaglandin E analogue inhibition of intrinsic factor release.
    Zucker KA; Adrian TE; Ballantyne GH; Modlin IM
    Scand J Gastroenterol; 1988 Aug; 23(6):650-4. PubMed ID: 3140367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of misoprostol on histamine-stimulated acid secretion and cyclic AMP formation in isolated canine parietal cells.
    Tsai BS; Kessler LK; Butchko GM; Bauer RF
    Dig Dis Sci; 1987 Sep; 32(9):1010-6. PubMed ID: 3040357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostaglandins and the dog stomach: effects of misoprostol on the proportion of mucosa to muscle and on the proportion of different epithelial cell types.
    Goodlad RA; Madgwick AJ; Moffatt MR; Levin S; Allen JL; Wright NA
    Digestion; 1990; 45(4):212-6. PubMed ID: 2119321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of rioprostil with the parietal cell prostaglandin E2 receptor.
    Beinborn M; Nüstedt V; Sewing KF
    Scand J Gastroenterol Suppl; 1989; 164():21-4; discussion 24-5. PubMed ID: 2554487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of misoprostol on cell migration and transit in the dog stomach.
    Goodlad RA; Madgwick AJ; Moffatt MR; Levin S; Allen JL; Wright NA
    Gastroenterology; 1990 Jan; 98(1):90-5. PubMed ID: 2104542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Misoprostol. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of peptic ulcer disease.
    Monk JP; Clissold SP
    Drugs; 1987 Jan; 33(1):1-30. PubMed ID: 3102205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of the prostaglandin analogue, misoprostol, on cell proliferation and cell migration in the canine stomach.
    Goodlad RA; Madgwick AJ; Moffatt MR; Levin S; Allen JL; Wright NA
    Digestion; 1990; 46 Suppl 2():182-7. PubMed ID: 2124557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antisecretory and mucosal protective actions of misoprostol. Potential role in the treatment of peptic ulcer disease.
    Wilson DE
    Am J Med; 1987 Jul; 83(1A):2-8. PubMed ID: 3113241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral prostaglandin E analogues induce intestinal migrating motor complexes after a meal in dogs. Evidence for a central mechanism.
    Staumont G; Fioramonti J; Frexinos J; Bueno L
    Gastroenterology; 1990 Apr; 98(4):888-93. PubMed ID: 2107114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perspective on the gastric antisecretory effects of misoprostol in man.
    Dajani EZ
    Prostaglandins; 1987; 33 Suppl():68-77. PubMed ID: 3122277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of prostaglandin E2 receptor sites in the embryonic murine palate.
    Jones J; Greene RM
    Prostaglandins Leukot Med; 1986 May; 22(2):139-51. PubMed ID: 2873584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Misoprostol and gastroduodenal mucosal protection (cytoprotection).
    Wilson DE
    Postgrad Med J; 1988; 64 Suppl 1():7-11. PubMed ID: 3138683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.